The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Xu, Qian ^a   Liu, Jing Wei ^a   He, Cai Yun ^a   Sun, Li Ping ^a   Gong, Yue Hua ^a   Jing, Jing Jing ^a   Xing, Chengzhong ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MICRORNA; DNA HELICASE; ERCC6 PROTEIN, HUMAN; MIRNLET7 MICRORNA, HUMAN; PEPSINOGEN II; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIUM DETECTION; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; ERCC6 GENE; FEMALE; GENE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PGC GENE; PRI LET 7A 1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; VERY ELDERLY; YOUNG ADULT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PRECANCER; RISK; STOMACH TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA HELICASES; DNA REPAIR ENZYMES; FEMALE; GASTRITIS, ATROPHIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PEPSINOGEN C; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; RISK; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84896099195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089203     Document Type: Article

References (25)

1. Xu Y, Liu L, Liu J, Zhang Y, Zhu J, et al. (2011) A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer 128: 412-417.
2. Zhang LS, Liang WB, Gao LB, Li HY, Li LJ, et al. (2012) Association between pri-miR-218 polymorphism and risk of hepatocellular carcinoma in a Han Chinese population. DNA Cell Biol 31: 761-765.
3. Arisawa T, Tahara T, Shiroeda H, Matsue Y, Minato T, et al. (2012) Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3′-UTR, influence susceptibility to gastric cancer. Hum Immunol 73: 747-752.
4. He C, Tu H, Sun L, Xu Q, Li P, et al. (2013) Helicobacter pylori-related host gene polymorphisms associated with susceptibility of gastric carcinogenesis: a two-stage case-control study in Chinese. Carcinogenesis 34: 1450-1457.
5. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M (2001) Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 69: 936-950. (Pubitemid 33015809)
6. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61. (Pubitemid 44698579)
7. Moore JH, Williams SM (2002) New strategies for identifying gene-gene interactions in hypertension. Ann Med 34: 88-95. (Pubitemid 34596846)
8. Cordell HJ (2009) Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 10: 392-404.
9. Moore JH (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56: 73-82.
10. Liu L, Wu C, Wang Y, Zhong R, Wang F, et al. (2011) Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 32: 336-342.
11. Sapkota Y, Mackey JR, Lai R, Franco-Villalobos C, Lupichuk S, et al. (2013) Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One 8: e64896.
12. Link A, Kupcinskas J, Wex T, Malfertheiner P (2012) Macro-role of microRNA in gastric cancer. Dig Dis 30: 255-267.
13. Mishra PJ, Bertino JR (2009) MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 10: 399-416.
14. Ning PF, Liu HJ, Yuan Y (2005) Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. World J Gastroenterol 11: 2545-2548.
15. Pines A, Hameetman L, de Wilde J, Alekseev S, de Gruijl FR, et al. (2010) Enhanced global genome nucleotide excision repair reduces UV carcinogenesis and nullifies strand bias in p53 mutations in Csb-/- mice. J Invest Dermatol 130: 1746-1749.
16. Liu J, He C, Sun L, Xu Q, Xing C, et al. (2013) ERCC6 rs1917799 T>G polymorphism associated with susceptibility to gastric cancer in Chinese population: a case-control study. Asian Pacific Journal of Cancer Prevention (accepted).
17. Zhu YM, Zhong ZX, Liu ZM (2010) Relationship between let-7a and gastric mucosa cancerization and its significance. World J Gastroenterol 16: 3325-3329.
18. Wang WN, Chen Y, Zhang YD, Hu TH (2013) The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer. Tumour Biol 34: 1865-1871.
19. Xu Q, Yuan Y, Sun LP, Gong YH, Xu Y, et al. (2009) Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int J Oncol 35: 1313-1320.
20. Liu JW, He CY, Sun LP, Xu Q, Xing CZ, et al. (2013) The DNA Repair Gene ERCC6 rs1917799 Polymorphism is Associated with Gastric Cancer Risk in Chinese. Asian Pac J Cancer Prev 14: 6103-6108.
21. Gong YH, Sun LP, Jin SG, Yuan Y (2010) Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis 29: 907-911.
22. Zhong R, Liu L, Zou L, Sheng W, Zhu B, et al. (2013) Genetic variations in the TGFbeta signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Carcinogenesis 34: 936-942.
23. Liu L, Wu J, Zhong R, Wu C, Zou L, et al. (2013) Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Mol Carcinog 52: 923-931.
24. Chen W, Song H, Zhong R, Zhu B, Guo H, et al. (2013) Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis. Breast Cancer Res Treat 142: 637-644.
25. He CY, Sun LP, Gong YH, Xu Q, Dong NN, et al. (2011) Serum pepsinogen II: a neglected but useful biomarker to differentiate between diseased and normal stomachs. J Gastroenterol Hepatol 26: 1039-1046.